Streamline Your Clinical Leukopak Supply Chain

There have been many changes in the clinical leukopak supply market in recent years – acquisitions, mergers, site closures, you name it.

We can streamline your contracting and quality needs into one end-to-end supply by contracting with Lonza to supply your apheresis material and handle your downstream manufacturing.

Having readily available starting material to create batches for patients when they are needed is an important aspect of your supply chain to consider.  We work with multiple collection sites for allogeneic donor material for leukopaks and mobilized leukopaks. 

For this offering concept, we can procure either fresh or cryopreserved leukopaks for downstream CAR-T/NK manufacturing or for an easy off-the-shelf option of GMP PBMCs we can offer D1 processing of leukopaks into cryopreserved vials or bags for next processing steps.

Clinical leukopaks in a few months’ time

• The basics of this timeline start with any donor and IRB requirements – everything must be set up correctly from a donor eligibility and collection standpoint to allow for downstream use for each client’s clinical indication

Lonza wants to help with your clinical bone marrow needs, whether you need a primary or secondary supplier, contact us today.